Mesenchymal stem cells therapy enhances the efficacy of pregabalin and prevents its motor impairment in paclitaxel-induced neuropathy in rats: Role of Notch1 receptor and JAK/STAT signaling pathway. [electronic resource]
Producer: 20190502Description: 303-311 p. digitalISSN:- 1872-7549
- Acetone -- toxicity
- Analysis of Variance
- Animals
- Antineoplastic Agents, Phytogenic -- toxicity
- Antioxidants -- metabolism
- Caspase 3 -- metabolism
- Cell- and Tissue-Based Therapy -- methods
- Disease Models, Animal
- Hyperalgesia -- physiopathology
- Interleukin-6 -- metabolism
- Janus Kinases -- metabolism
- Male
- Mesenchymal Stem Cells -- physiology
- Motor Disorders -- etiology
- Nerve Growth Factor -- metabolism
- Paclitaxel -- toxicity
- Pregabalin -- therapeutic use
- Rats
- Rats, Wistar
- Receptor, Notch1 -- metabolism
- Rotarod Performance Test
- STAT Transcription Factors -- metabolism
- Sciatic Neuropathy -- chemically induced
- Time Factors
- Tumor Necrosis Factor-alpha -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.